Author: OurCrowd

[Alpha Tau in GlobeNewswire] Alpha Tau appoints industry veteran Peter Melnyk as Chief Commercial Officer

JERUSALEM, Sept. 01, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that Peter Melnyk, a member of its board of directors, has resigned from the Company’s Board of Directors in order to assume the full-time position of Alpha Tau’s Chief Commercial Officer. Read...

Read More

[Terra CO2 in PRWeb] Terra CO2 Technology announces results of their participation in the Minnesota Road Research Facility project

Terra CO2 Technology, the scalable low carbon alternative for cement production, announced today the preliminary results of their OPUS supplementary cementitious material used in the Minnesota Road Research Facility (MnROAD) on Interstate 94. For the project, Terra delivered 20 tons of their proprietary OPUS SCM (Supplementary Cementitious Material). Terra’s materials were used without the need for adaptations or new investments, proving OPUS’s sustainable approach is ready to be used with the current infrastructure. Read...

Read More

[Insightec in PR Newswire] Insightec announces financing up to $200 million to fund continued growth

HAIFA, Israel and MIAMI, Sep. 1, 2022 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that it signed a credit facility for up to $200 million with affiliates of existing shareholders Perceptive Advisors and Community Fund. The financing has provided Insightec with $100 million at closing, with an additional $100 million of financing potentially available in tranches through 2024. The credit facility is interest-only for five years and matures on August 31, 2027. Read...

Read More